Proceedings of the National Academy of Sciences · 2003 · 146 citations · 43 references
Life SciencesCell BiologyPharmacologyApoptosisInflammationSignal TransductionApoptotic SignalingCaspase ActivationGastrointestinal InflammationInflammatory SignalingIntestinal Barrier FunctionMucosal PermeabilityApoptosis In Mucosal EpitheliumApoptosis Signaling PathwaysEpithelial ApoptosisEpithelial Barrier PermeabilityGastrointestinal Barrier DysfunctionInflammation-induced Barrier DisruptionInflammation-related Barrier DysfunctionReceptor-mediated Apoptosis
Proteinase-activated receptor 1 (PAR1)-mediated inflammation remains poorly understood. Here we characterize previously unrecognized effects of PAR1-induced apoptosis signaling, which contributes to epithelial barrier dysfunction. Incubation of epithelial cells with PAR1 agonists induced apoptosis and increased epithelial permeability in a caspase-3-dependent manner. Similarly, studies in vivo demonstrated that intracolonic infusion with PAR1 agonists increased colonic permeability in mice, and that this effect was abolished by pretreatment with a caspase-3 inhibitor. PAR1 agonists induced tight junctional zonula-occludens 1 disruption and apoptotic nuclear condensation. Investigation into signaling pathways showed that these effects were dependent on caspase-3, tyrosine kinase, and myosin light chain kinase. Conversely, the Src kinase inhibitor PP1 augmented zonula-occludens 1 injury and nuclear condensation induced by PAR1 agonists. These results support a role for proteinases and PARs in intestinal disease and provide new directions for possible therapeutic applications of PAR1 antagonists.
43
Proteinase-activated Receptors
Scott R. Macfarlane, Michael J. Seatter, Toru Kanke et al. · 2006 · 1.1K citations